Press Releases

Date Title and Summary View
Toggle Summary NxStage Celebrates Over 5,000 Home Hemodialysis Patients Receiving Kidney Transplants
LAWRENCE, Mass. , Dec. 11, 2017 /PRNewswire/ --  NxStage Medical, Inc . (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care , celebrates the achievement of over five thousand patients having received a kidney transplantation after performing more frequent home
View HTML
Toggle Summary Nx2me Connected Health® Improves Home Hemodialysis Retention
LAWRENCE, Mass. , Dec. 7, 2017 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced new results in Hemodialysis International , demonstrating its remote patient management system, Nx2me Connected Health , reduces
View HTML
Toggle Summary Eleven Unique NxStage Abstracts Accepted for 2017 Kidney Week
New studies being showcased at the American Society of Nephrology Congress confirm interim results from FREEDOM study and present new data on therapy retention and graduation rates.
View HTML
Toggle Summary NxStage Announces Stockholder Approval Of Merger Agreement With Fresenius Medical Care
LAWRENCE, Mass. , Oct. 27, 2017 /PRNewswire/ --  NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care , today announced that at a special meeting of stockholders held today, the Company's stockholders voted to adopt the previously announced
View HTML
Toggle Summary NxStage Announces Winners of Third Annual Nurse Hero Award
Four nurses honored for exceptional dedication to patients
View HTML
Toggle Summary NxStage Medical Announces FDA Clearance for Solo Home Hemodialysis Using NxStage® System One™
First clearance of its kind gives trained NxStage patients freedom to dialyze without a care partner
View HTML
Toggle Summary NxStage System One Now in Nine of Top Ten U.S. Nephrology Hospitals
LAWRENCE, Mass. , Aug. 24, 2017 /PRNewswire/ --  NxStage Medical, Inc.  (Nasdaq: NXTM),  a leading medical technology company focused on advancing renal care , today announced that the NxStage® System One™ is now used in nine of the top ten nephrology hospitals in the United States , and
View HTML
Toggle Summary NxStage Kidney Care and Dialyze Direct to Provide On-Site Dialysis to Skilled Nursing Facility Patients in Ohio
LAWRENCE, Mass. , Aug. 11, 2017 /PRNewswire/ --  NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care , today announced that its NxStage Kidney Care subsidiary is partnering with Dialyze Direct, a leader in the area of geriatric dialysis and an
View HTML
Toggle Summary NxStage Reports Second Quarter Financial Results
- Company and Fresenius Medical Care Announce Definitive Agreement under which Fresenius Medical Care Will Acquire NxStage for $30.00 Per Share- Revenue Increases to $96.2 million, up 4% from Q2'FY16- Company Advances Pipeline with Launch of NxGen Hemodialysis System in NxStage Kidney Care
View HTML
Toggle Summary Fresenius Medical Care to Acquire NxStage Medical, Inc. to Strengthen Its Vertically Integrated Dialysis Business
Acquisition of NxStage Medical, Inc. would: position Fresenius Medical Care as a global leader in home dialysis establish U.S. presence in the critical care space further enhance clinical outcomes and patient empowerment support strategic initiative of vertical integration and Care Coordination
View HTML